1. Home
  2. Browse
  3. National Institutes of Health
  4. PAR-25-059

PAR-25-059National Institutes of HealthR61

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)

Deadline
Award ceiling
$750,000
Awards
Not stated
Posted
Oct 22, 2024

Official announcement on the NIH Guide · opens the funder's page. Always confirm dates there.

Or read the full text and all 3 review criteria here, free with an account. Create free account

Summary

This funding opportunity announcement (FOA) encourages research grant applications to develop in vitro and/or ex vivo assays and conduct iterative screening efforts to identify and characterize potential therapeutic agents for neurological or neuromuscular disorders…

Related NIH announcements6

Other open R61 announcements on related subjects, with at least two weeks to go.

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

RFA-CA-27-001National Institutes of Health4 review criteria on file

$150k

NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)

PAR-25-269National Institutes of Health3 review criteria on file

$350k

Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)

PAR-25-158National Institutes of Health3 review criteria on fileagency framework

—

HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)

RFA-NS-25-023National Institutes of Health4 review criteria on file

$350k

Translational Neural Devices (R61/R33 - Clinical Trial Optional)

PAR-25-053National Institutes of Health3 review criteria on file

—

NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)

PAR-25-026National Institutes of Health3 review criteria on file

—

The full announcement, free with an account

  • The full announcement text, not just the first two sentences
  • All 3 review criteria reviewers score this against, extracted from this announcement

On Plus, $39 a month

  • The eligibility check against your profile: career stage, institution type, and the windows that close before the deadline does
  • Funded precedents: what similar NIH projects received, from the award records in NIH RePORTER
  • A Reviewer Scorecard of your draft against these criteria
Create free accountSign in

No card required. Browsing is free.

More from National Institutes of Health

Open now with at least two weeks to apply, soonest deadline first.

Limited Competition for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Clinical Centers (U01 Clinical Trial Required)

RFA-DK-27-125National Institutes of Health

—

Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)

PAR-25-374National Institutes of Health3 review criteria on fileagency framework

$1M

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)

PAR-25-095National Institutes of Health3 review criteria on file

$350k

BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed)

RFA-DA-27-004National Institutes of Health3 review criteria on file

—

Everything open from National Institutes of Health

Hiring in this research area now

All drug discovery jobs

Source record: https://grants.nih.gov/grants/guide/pa-files/PAR-25-059.htmlVia the NIH Guide. Last checked against the source . Always confirm dates with the funder.